MAD2L1 and cancer: In conclusion, the present study has shown that CDK1 and MAD2L1 are overexpressed in LUAD tissues and that its up-regulation may be indicative of poor survival rates and a higher risk for cancer recurrence, and it could have a potential role as a prognostic marker in LUAD patients.